[SCHEDULE 13G/A] Amplitude, Inc. SEC Filing

Rhea-AI Filing Summary

FMR LLC—parent of Fidelity Investments—and its CEO Abigail P. Johnson filed a Schedule 13G disclosing passive ownership of 38,760,723 AGL common shares as of 30 Jun 2025. The position equals 9.4 % of agilon health’s outstanding stock, crossing the 5 % reporting threshold. FMR reports sole voting power over 38.74 M shares and sole dispositive power over the total stake; no shared voting or dispositive authority exists. The filing is made under Rule 13d-1(b), indicating the securities are held in the ordinary course of business and not to influence corporate control.

The certification states that certain underlying clients may receive dividends or sale proceeds, but none individually holds more than 5 % of the class. No transactions, agreements, or takeover intentions are disclosed. The update simply informs the market that Fidelity-managed funds and accounts collectively maintain a substantial passive investment in agilon health, inc. (symbol AGL).

Positive

• Fidelity’s 9.4 % ownership provides strong institutional backing, potentially improving market perception and liquidity for AGL shares.

Negative

• None.

Insights

Securities Analyst

TL;DR: Fidelity now owns 9.4 % of AGL, a sizeable passive stake that may boost liquidity and investor confidence.

FMR LLC’s 38.8 M-share position signals strong institutional interest from a blue-chip asset manager. While the 13G is passive and lacks activism intent, the magnitude—nearly one-tenth of the float—can tighten supply, enhance trading volumes, and serve as an implicit vote of confidence in management’s strategy. Because Fidelity is diversified, rapid liquidation risk is low, reducing overhang concerns. The market often views new or enlarged positions by top-tier institutions as mildly positive for valuation multiples.

Corporate Governance Expert

TL;DR: Stake is passive; no governance or control implications identified.

The Rule 13d-1(b) filing classifies FMR as a parent holding company, not an activist. Sole voting/dispositive powers remain with FMR, and no group or control intent is declared. Therefore, investors should not expect board nominations or policy interventions arising from this stake. Governance dynamics remain unchanged, and any future shift to a 13D filing would be the trigger for heightened scrutiny.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 3)

AMPLITUDE INC

(Name of Issuer)

CLASS A COMMON STOCK

(Title of Class of Securities)

03213A104

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 03213A104

1

Names of Reporting Persons

FMR LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 3,279,820.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 3,288,480.96
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,288,480.96

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

3.3 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

CUSIP No. 03213A104

1

Names of Reporting Persons

Abigail P. Johnson

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 3,288,480.96
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,288,480.96

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

3.3 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: AMPLITUDE INC
(b)	Address of issuer's principal executive offices: 201 THIRD STREET,Suite 200,SAN FRANCISCO,CA,USA,94103
Item 2.
(a)	Name of person filing: FMR LLC
(b)	Address or principal business office or, if none, residence: 245 Summer Street, Boston, Massachusetts 02210
(c)	Citizenship: Not applicable
(d)	Title of class of securities: CLASS A COMMON STOCK
(e)	CUSIP No.: 03213A104
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 3288480.96
(b)	Percent of class: 3.3 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Please see the responses to Items 5 and 6 on the cover page.
	(ii) Shared power to vote or to direct the vote: 0.00
	(iii) Sole power to dispose or to direct the disposition of: 3288480.96
	(iv) Shared power to dispose or to direct the disposition of: 0.00
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the CLASS A COMMON STOCK of AMPLITUDE INC. No one other person's interest in the CLASS A COMMON STOCK of AMPLITUDE INC is more than five percent of the total outstanding CLASS A COMMON STOCK.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See attached Exhibit 99.
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

FMR LLC

Signature:	Richard Bourgelas
Name/Title:	Duly authorized under Power of Attorney effective as of May 23, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries*
Date:	08/05/2025

Abigail P. Johnson

Signature:	Richard Bourgelas
Name/Title:	Duly authorized under Power of Attorney effective as of May 23, 2023, by and on behalf of Abigail P. Johnson*
Date:	08/05/2025

Comments accompanying signature: *This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on August 8, 2023, accession number: 0000315066-23-002397.

Exhibit Information

Please see Exhibit 99 for 13d-1(k) (1) agreement.

FAQ

How many agilon health (AGL) shares does FMR LLC own?

FMR reports beneficial ownership of 38,760,723 common shares.

What percentage of AGL’s outstanding shares does Fidelity control?

The stake represents 9.4 % of the outstanding common stock.

Does the 13G filing indicate activist intentions by FMR LLC?

No. Filed under Rule 13d-1(b), it classifies the position as passive and held in the ordinary course of business.

Who has voting and dispositive power over the AGL shares?

FMR enjoys sole voting power over 38.74 M shares and sole dispositive power over the entire 38.76 M shares; no shared powers are reported.

When was the ownership position effective and when was the filing signed?

The ownership is reported as of 30 Jun 2025, and the filing was signed on 05 Aug 2025.